Skip to main content

Latest News

26/03/21
Call for new members

The All Wales Medicines Strategy Group (AWMSG) is seeking new members for the parent committee and its subgroups – the New Medicines Group (NMG) and the All Wales Prescribing Advisory Group (AWPAG).

23/03/21
AWMSG Chair update

Professor Ceri Phillips has stepped down as Chair of the All Wales Medicines Strategy Group (AWMSG) to take up the appointment of Vice Chair, Cardiff and Vale University Health Board.

18/03/21
New medicines advice for NHS Wales

Welsh Government has approved advice from the All Wales Medicines Strategy Group (AWMSG) for five medicines.

26/01/21
In review: AWMSG publishes Annual Report 2019-2020

In a new look All Wales Medicines Strategy Group (AWMSG) annual report, read an overview of 2019-2020 as AWMSG embarks on a new chapter.

31/12/20
AWMSG hosts first virtual Open Day for Pharmaceutical Industry

The All Wales Medicines Strategy Group (AWMSG) team continue to adapt to a new way of working with the launch of a virtual Open Day programme for the pharmaceutical industry.

13/11/20
New medicines advice for NHS Wales

Welsh Government has approved advice from the All Wales Medicines Strategy Group (AWMSG) for extending the use of a medicine.

23/10/20
New medicines advice for NHS Wales

Welsh Government has approved new advice from the All Wales Medicines Strategy Group (AWMSG) for one medicine.

25/09/20
New medicines advice for NHS Wales

Welsh Government has approved new advice from the All Wales Medicines Strategy Group (AWMSG) for three medicines.

17/09/20
AWMSG supports World Patient Safety Day 2020

The All Wales Medicines Strategy Group (AWMSG) joins health care professionals across the world in supporting World Patient Safety Day 2020.

05/08/20
New medicines advice for NHS Wales

Welsh Government has approved new advice from the All Wales Medicines Strategy Group (AWMSG) for three medicines.

06/07/20
AWTTC expands educational remit with new collaboration

The All Wales Therapeutics and Toxicology Centre (AWTTC) has worked in conjunction with Health Education and Improvement Wales (HEIW) on a new module that launched in June.

30/06/20
Positive review by AWMSG sees HIV prevention drug made routinely available in Wales

After a successful Welsh Government funded study, a pre-exposure prophylaxis HIV prevention drug combination will be routinely available to those eligible across Wales.

25/03/20
Coronavirus (COVID-19) - therapeutic advice

AWTTC has compiled a series of resources for prescribers and patients to help with the appropriate use of medicines during the current pandemic. These can be accessed from the AWTTC COVID-19 Therapeutic Hub.

18/02/20
New medicines advice for NHS Wales

Welsh Government has approved new advice from the All Wales Medicines Strategy Group (AWMSG) for two medicines, dolutegravir/lamivudine (Dovato®) and plerixafor (Mozobil®) 

20/12/19
Presentation at 5th Annual Welsh Rare Disease Patient Network Meeting

The AWMSG process for appraising medicines used to treat rare conditions was outlined and the results from a review of the process were presented.

13/12/19
New medicines advice for NHS Wales

Welsh Government has approved new advice from the All Wales Medicines Strategy Group (AWMSG) for two medicines, fampridine (Fampyra®) and glycerol phenylbutyrate (Ravicti®). 

03/12/19
New medicines advice for NHS Wales

Welsh Government has approved advice from the All Wales Medicines Strategy Group (AWMSG) for four new medicines, cefepime dihydrochloride monohydrate (Renapime®), diamorphine hydrochloride (Ayendi®), dupilumab (Dupixent®) and melatonin (Slenyto®).

25/10/19
New medicines advice for NHS Wales

Welsh Government has approved new advice from the All Wales Medicines Strategy Group (AWMSG) for two medicines zanamivir (Dectova®) and glecaprevir/pibrentasvir (Maviret®). 

25/07/19
New Chair appointed to All Wales Medicines Strategy Group

Health Minister, Vaughan Gething has today (Thursday 25 July) announced the appointment of Professor Ceri Phillips as the new Chair of the All Wales Medicines Strategy Group (AWMSG) for a four year period.